Tonghua Dongbao Pharmaceutical Co., Ltd. Stock Price

SHSE:600867 Community·CN¥16.3b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create Narrative

600867 Share Price Performance

CN¥0

-7.88 (-100.00%)

CN¥0

-7.88 (-100.00%)

CN¥0

Wed, 3 Jun 26

Share Pricen/a

600867 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet average dividend payer.

2 Risks

3 Rewards

View Full Analysis

Tonghua Dongbao Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.63
: 70.48%
: 40.64%
: 9.2%

View Full Analysis

About 600867

Founded: 1985
Employees: 3354
CEO: Chun Sheng Leng
WebsiteView website: www.thdb.com

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metformin hydrochloride tablets. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.